Effect of prolactin on the secretion of hypothalamic GnRH and pituitary gonadotropins.
In order to clarify the mechanism by which excess PRL inhibits gonadotropin release, in vivo and in vitro studies were performed with adult female rats. First, we examined the effect of hyperprolactinemia, produced by implantation of anterior pituitary glands under the kidney capsule, on catecholamine turnover in the medial basal hypothalamus (MBH) and on GnRH concentrations in MBH and hypophyseal portal blood. Rats bearing pituitary transplants exhibited increased turnovers of dopamine (DA) in the MBH, decreased concentrations of GnRH in the MBH and in plasma of hypophyseal portal blood and impaired gonadotropin release from the pituitary gland. Second, we examined the effects of PRL on DA release and of DA on GnRH release from rat hypothalamic cells. We observed that PRL stimulated [3H] DA release, and DA inhibited ionophore-induced GnRH release from dispersed hypothalamic cells. Third, we examined the effect of PRL on estrogen-induced LH release using the in vitro perfusion system. We found that administration of PRL suppressed estrogen-induced LH release by suppressing GnRH release from the hypothalamus. These findings suggest that chronic hyperprolactinemia may increase dopaminergic tone in the MBH that may inhibit GnRH secretion from the MBH and LH release from the pituitary and that these processes may be responsible for disturbances of cyclic hypothalamic pituitary-ovarian activity.
Koike
K
K
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.
Miyake
A
A
Aono
T
T
Sakumoto
T
T
Ohmichi
M
M
Yamaguchi
M
M
Tanizawa
O
O
D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005640:Follicle Stimulating Hormone / Q000096:biosynthesis; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D006065:Gonadotropins, Pituitary / Q000378:metabolism*; D006966:Hyperprolactinemia / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000096:biosynthesis; D009638:Norepinephrine / Q000096:biosynthesis; D010293:Pargyline / Q000494:pharmacology; D010902:Pituitary Gland / Q000502:physiology / Q000637:transplantation; D011388:Prolactin / Q000502:physiology*; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains
D002395:Catecholamines; D006065:Gonadotropins, Pituitary; D007987:Gonadotropin-Releasing Hormone; D000001:Calcimycin; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D010293:Pargyline; D002118:Calcium; D004298:Dopamine; D009638:Norepinephrine